Cargando…
Review of icatibant use in the Winnipeg Regional Health Authority
BACKGROUND: This is a retrospective review of the Winnipeg Regional Health Authority’s (WRHA) angioedema patients who were dispensed icatibant in hospital. Icatibant is a bradykinin B2 receptor antagonist indicated for Hereditary Angioedema (HAE) types I and II and is used off-label for HAE with nor...
Autores principales: | Cai, George, Barber, Colin, Kalicinsky, Chrystyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656671/ https://www.ncbi.nlm.nih.gov/pubmed/33292436 http://dx.doi.org/10.1186/s13223-020-00493-3 |
Ejemplares similares
-
Treatment of angiotensin-converting enzyme inhibitor related angioedema with icatibant
por: Ho, Peter, et al.
Publicado: (2014) -
Adult-onset IgE-mediated food allergy at a Winnipeg allergy clinic: a case series
por: Walter, Graham, et al.
Publicado: (2020) -
A novel combination of an IgE mediated adult onset food allergy and a suspected mast cell activation syndrome presenting as anaphylaxis
por: Barber, Colin, et al.
Publicado: (2016) -
Review of the Manitoba cohort of patients with hereditary angioedema with normal C1 inhibitor
por: McKibbin, Lundy, et al.
Publicado: (2019) -
A retrospective comparison of false negative skin test rates in penicillin allergy, using pencilloyl-poly-lysine and minor determinants or Penicillin G, followed by open challenge
por: Rosenfield, Lana, et al.
Publicado: (2015)